HR 2592: Aviation Medication Transparency Act of 2025

HR 2592 in plain English: This bill requires the FAA to create, publish, and update annually a list of medications that pilots and air traffic controllers may safely take while still qualifying for medical certification. The list must be posted on the FAA website and shared with anyone seeking a license or medical certification.

Stated purpose

The bill requires the FAA to publish and keep updated a publicly available list of medications that pilots and air traffic controllers may safely take while holding medical certification, making that information accessible to airmen and their doctors.

Key points

• Requires the FAA to compile and publish a list of medications safe for pilots and air traffic controllers to use
• List must be updated annually and posted publicly on the FAA website
• FAA must distribute the list to people seeking aviation licenses and medical certification
• Currently the FAA only publishes lists of medications pilots must not take, not approved ones

Arguments supporters make

• Pilots and controllers currently have no single public list of approved medications, so making it transparent removes guesswork and helps aviation workers make informed health decisions without fear of unknowingly losing their certification.
• Doctors who treat pilots or controllers often do not know FAA medication rules; a public list with a contact mechanism lets them prescribe more accurately and avoid grounding their patients unnecessarily.
• Greater clarity about which medications are allowed could encourage aviation workers to seek treatment for medical conditions they might otherwise hide, potentially improving overall safety.

Arguments opponents make

• Publishing a comprehensive approved-medication list could be quickly outdated as new drugs enter the market, and annual updates may not keep pace with medical advances, giving pilots a false sense of certainty.
• Creating and maintaining a detailed, user-friendly public list adds a bureaucratic burden to the FAA, which may divert resources from other safety oversight functions.
• A publicly available list of approved medications could be misused by individuals seeking to game the certification system by choosing medications specifically because they appear on the approved list, rather than because they are the best medical treatment.

Tradeoffs

Making medication rules transparent and accessible helps aviation workers and their doctors but places a new ongoing compliance and publishing burden on the FAA; the benefit of greater openness must be weighed against the risk that a static or slow-to-update list could create false confidence or be exploited.

Current status in Congress: In committee.

NewsClear — neutral news & congressional tracking · Bill of the Week